Development and Verification of a Linked
Conducting clinical trials to understand the exposure riskbenefit relationship of cannabis use is not always feasible. Alternatively, physiologically based pharmacokinetic (PBPK) models can be used to predict exposure of the psychoactive cannabinoid (-)-Δ